Phospholipase A2 항체와 관련상품
산타크루즈 바이오테크놀로지는 연구용 포스포리파아제 A2 단일 클론 항체의 포괄적인 컬렉션을 제공합니다. 포스포리파제 A2 항체는 웨스턴 블롯팅(WB), 면역 침전(IP), 면역 형광(IF), 파라핀 내장 섹션을 이용한 면역 조직 화학(IHCP), 유세포 분석(FCM), 효소 결합 면역 흡착 분석(ELISA) 등 여러 기술에 대한 검증을 거쳤습니다. 포스포리파아제 A2는 인지질 가수분해에 중요한 역할을 하여 염증과 세포 신호 전달에 관여하는 생리 활성 지질의 전구체인 아라키돈산을 방출하는 데 중요한 역할을 합니다. 이 효소는 막 리모델링과 염증 반응 조절을 비롯한 다양한 생리학적 과정에 필수적인 역할을 합니다. 포스포리파아제 A2의 기능을 이해하는 것은 천식, 관절염, 암과 같은 질병에 미치는 영향을 규명하는 데 매우 중요합니다. 연구자들은 특정 단일 클론 항체를 활용하여 다양한 조직 유형에서 포스포리파아제 A2의 발현 패턴을 조사할 수 있습니다. 과학자들은 첨단 연구 방법을 통해 포스포리파제 A2가 신호 경로에서 다른 분자와 어떻게 상호 작용하는지 조사할 수 있습니다. 산타크루즈 바이오테크놀로지의 포스포리파제 A2 단일 클론 항체는 전 세계 연구자들이 세포 과정과 질병 메커니즘에 대한 이해를 발전시키는 데 도움을 줍니다.
Phospholipase A2 항체
| Empty Table Header | 제품명 | 카탈로그# | ISOTYPE | EPITOPE | APPLICATIONS | Species | 引用 | RATING |
|---|---|---|---|---|---|---|---|---|
group II sPLA2 항체 (SCACC353) | sc-58363 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P), ELISA | h | 4 | ||
group IVD sPLA2 항체 (H-6) | sc-398758 | mouse IgG3 κ | 805-828 (m) | WB, IP, IF, ELISA | m, r, h | new | ||
group IVF sPLA2 항체 (C-6) | sc-398729 | mouse IgG1 κ | 794-821 (m) | WB, IP, IF, ELISA | m, r, h | new | ||
group V PLA2 항체 (C-4) | sc-393606 | mouse IgG1 κ | FL (m) | WB, IP, IF, IHC(P), ELISA | m, r, h | 2 | ||
group V PLA2 항체 (1B7) | sc-20023 | mouse IgG1 κ | FL (h) | IF | m, r, h | new | ||
group V PLA2 항체 (3G1) | sc-18828 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P), FCM | m, r, h | 2 | ||
group V PLA2 항체 (2A5) | sc-20024 | mouse IgG1 κ | FL (h) | IF | h | new | ||
group VI iPLA2 항체 (D-4) | sc-376563 | mouse IgG1 κ | 727-759 (h) | WB, IP, IF, ELISA | m, r, h | 10 | ||
group VI iPLA2 항체 (A-10) | sc-137189 | mouse IgG1 κ | 1-120 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
group VI iPLA2 항체 (E-8) | sc-166616 | mouse IgG2b κ | 1-120 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 4 | ||
group X sPLA2 항체 (E-4) | sc-514324 | mouse IgG1 κ | 81-155 (h) | WB, IP, IF, ELISA | m, r, h | 1 | ||
group XIIA sPLA2 항체 (SP-34) | sc-134352 | mouse IgG1 κ | 90-189 (h) | WB, IP, ELISA | h | new | ||
group XIIA sPLA2 항체 (E-9) | sc-514423 | mouse IgG2a κ | 111-170 (h) | WB, IP, IF, ELISA | m, r, h | new |
Phospholipase A2 CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 제품명 | 카탈로그# | Species | APPLICATIONS | MARKER | 引用 | RATING |
|---|---|---|---|---|---|---|---|
group IB sPLA2 CRISPR/Cas9 케이오 플라스미드 (h) | sc-407667 | h | Gene Knockout | GFP | 0 | ||
group IB sPLA2 HDR 플라스미드 (h) | sc-407667-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
group IB sPLA2 더블 틈내기효소 플라스미드 (h) | sc-407667-NIC | h | Gene Knockout | Puromycin | 0 | ||
group IB sPLA2 더블 틈내기효소 플라스미드 (h2) | sc-407667-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
group IB sPLA2 CRISPR/Cas9 케이오 플라스미드 (m) | sc-422279 | m | Gene Knockout | GFP | 0 | ||
group IB sPLA2 HDR 플라스미드 (m) | sc-422279-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
group IB sPLA2 더블 틈내기효소 플라스미드 (m) | sc-422279-NIC | m | Gene Knockout | Puromycin | 0 | ||
group IB sPLA2 더블 틈내기효소 플라스미드 (m2) | sc-422279-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
group II sPLA2 Double Nickase Plasmid (h) | sc-402234-NIC | h | Gene Knockout | Puromycin | 0 | ||
group II sPLA2 Double Nickase Plasmid (h2) | sc-402234-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
group II sPLA2 CRISPR/Cas9 케이오 플라스미드 (m) | sc-422281 | m | Gene Knockout | GFP | 0 | ||
group II sPLA2 HDR 플라스미드 (m) | sc-422281-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
group II sPLA2 더블 틈내기효소 플라스미드 (m) | sc-422281-NIC | m | Gene Knockout | Puromycin | 0 | ||
group II sPLA2 더블 틈내기효소 플라스미드 (m2) | sc-422281-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
group II sPLA2 CRISPR/Cas9 KO Plasmid (h2) | sc-402234-KO-2 | h | Gene Knockout | GFP | 0 | ||
group II sPLA2 HDR Plasmid (h2) | sc-402234-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
group IIC sPLA2 CRISPR/Cas9 케이오 플라스미드 (h) | sc-415910 | h | Gene Knockout | GFP | 0 | ||
group IIC sPLA2 HDR 플라스미드 (h) | sc-415910-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
group IIC sPLA2 더블 틈내기효소 플라스미드 (h) | sc-415910-NIC | h | Gene Knockout | Puromycin | 0 | ||
group IIC sPLA2 더블 틈내기효소 플라스미드 (h2) | sc-415910-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
group IIC sPLA2 CRISPR/Cas9 케이오 플라스미드 (m) | sc-422282 | m | Gene Knockout | GFP | 0 | ||
group IIC sPLA2 HDR 플라스미드 (m) | sc-422282-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
group IIC sPLA2 더블 틈내기효소 플라스미드 (m) | sc-422282-NIC | m | Gene Knockout | Puromycin | 0 | ||
group IIC sPLA2 더블 틈내기효소 플라스미드 (m2) | sc-422282-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
group IID sPLA2 CRISPR/Cas9 케이오 플라스미드 (h) | sc-411908 | h | Gene Knockout | GFP | 1 | ||
group IID sPLA2 HDR 플라스미드 (h) | sc-411908-HDR | h | Homology Directed Repair | Puromycin | 1 | ||
group IID sPLA2 더블 틈내기효소 플라스미드 (h) | sc-411908-NIC | h | Gene Knockout | Puromycin | 1 | ||
group IID sPLA2 더블 틈내기효소 플라스미드 (h2) | sc-411908-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
group IID sPLA2 CRISPR/Cas9 케이오 플라스미드 (m) | sc-422283 | m | Gene Knockout | GFP | 0 | ||
group IID sPLA2 CRISPR/Cas9 케이오 플라스미드 (m2) | sc-422283-KO-2 | m2 | Gene Knockout | GFP | 0 | ||
group IID sPLA2 HDR 플라스미드 (m2) | sc-422283-HDR-2 | m2 | Homology Directed Repair | Puromycin | 0 | ||
group IID sPLA2 더블 틈내기효소 플라스미드 (m) | sc-422283-NIC | m | Gene Knockout | Puromycin | 0 | ||
group IID sPLA2 더블 틈내기효소 플라스미드 (m2) | sc-422283-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
group IIE sPLA2 CRISPR/Cas9 케이오 플라스미드 (h) | sc-408058 | h | Gene Knockout | GFP | 0 | ||
group IIE sPLA2 HDR 플라스미드 (h) | sc-408058-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
group IIE sPLA2 더블 틈내기효소 플라스미드 (h) | sc-408058-NIC | h | Gene Knockout | Puromycin | 0 | ||
group IIE sPLA2 더블 틈내기효소 플라스미드 (h2) | sc-408058-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
group IIE sPLA2 CRISPR/Cas9 케이오 플라스미드 (m) | sc-424164 | m | Gene Knockout | GFP | 0 | ||
group IIE sPLA2 HDR 플라스미드 (m) | sc-424164-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
group IIE sPLA2 더블 틈내기효소 플라스미드 (m) | sc-424164-NIC | m | Gene Knockout | Puromycin | 0 | ||
group IIE sPLA2 더블 틈내기효소 플라스미드 (m2) | sc-424164-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
group IIF sPLA2 CRISPR/Cas9 케이오 플라스미드 (h) | sc-410098 | h | Gene Knockout | GFP | 0 | ||
group IIF sPLA2 HDR 플라스미드 (h) | sc-410098-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
group IIF sPLA2 더블 틈내기효소 플라스미드 (h) | sc-410098-NIC | h | Gene Knockout | Puromycin | 0 | ||
group IIF sPLA2 더블 틈내기효소 플라스미드 (h2) | sc-410098-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
group IIF sPLA2 CRISPR/Cas9 케이오 플라스미드 (m) | sc-424165 | m | Gene Knockout | GFP | 0 | ||
group IIF sPLA2 HDR 플라스미드 (m) | sc-424165-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
group IIF sPLA2 더블 틈내기효소 플라스미드 (m) | sc-424165-NIC | m | Gene Knockout | Puromycin | 0 | ||
group IIF sPLA2 더블 틈내기효소 플라스미드 (m2) | sc-424165-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
group III sPLA2 CRISPR/Cas9 케이오 플라스미드 (h) | sc-412075 | h | Gene Knockout | GFP | 0 | ||
group III sPLA2 HDR 플라스미드 (h) | sc-412075-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
group III sPLA2 더블 틈내기효소 플라스미드 (h) | sc-412075-NIC | h | Gene Knockout | Puromycin | 0 | ||
group III sPLA2 더블 틈내기효소 플라스미드 (h2) | sc-412075-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
group III sPLA2 CRISPR/Cas9 케이오 플라스미드 (m) | sc-433569 | m | Gene Knockout | GFP | 0 | ||
group III sPLA2 HDR 플라스미드 (m) | sc-433569-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
group III sPLA2 더블 틈내기효소 플라스미드 (m) | sc-433569-NIC | m | Gene Knockout | Puromycin | 0 | ||
group III sPLA2 더블 틈내기효소 플라스미드 (m2) | sc-433569-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
group IVB sPLA2 CRISPR/Cas9 케이오 플라스미드 (h) | sc-410470 | h | Gene Knockout | GFP | 0 | ||
group IVB sPLA2 HDR 플라스미드 (h) | sc-410470-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
group IVB sPLA2 더블 틈내기효소 플라스미드 (h) | sc-410470-NIC | h | Gene Knockout | Puromycin | 0 | ||
group IVB sPLA2 더블 틈내기효소 플라스미드 (h2) | sc-410470-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
group IVC sPLA2 CRISPR/Cas9 케이오 플라스미드 (h) | sc-411191 | h | Gene Knockout | GFP | 0 | ||
group IVC sPLA2 HDR 플라스미드 (h) | sc-411191-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
group IVC sPLA2 더블 틈내기효소 플라스미드 (h) | sc-411191-NIC | h | Gene Knockout | Puromycin | 0 | ||
group IVC sPLA2 더블 틈내기효소 플라스미드 (h2) | sc-411191-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
group IVC sPLA2 CRISPR/Cas9 케이오 플라스미드 (m) | sc-433207 | m | Gene Knockout | GFP | 0 | ||
group IVC sPLA2 HDR 플라스미드 (m) | sc-433207-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
group IVC sPLA2 더블 틈내기효소 플라스미드 (m) | sc-433207-NIC | m | Gene Knockout | Puromycin | 0 | ||
group IVC sPLA2 더블 틈내기효소 플라스미드 (m2) | sc-433207-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
group IVD sPLA2 CRISPR/Cas9 케이오 플라스미드 (h) | sc-415332 | h | Gene Knockout | GFP | 0 | ||
group IVD sPLA2 HDR 플라스미드 (h) | sc-415332-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
group IVD sPLA2 더블 틈내기효소 플라스미드 (h) | sc-415332-NIC | h | Gene Knockout | Puromycin | 0 | ||
group IVD sPLA2 더블 틈내기효소 플라스미드 (h2) | sc-415332-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
group IVD sPLA2 CRISPR/Cas9 케이오 플라스미드 (m) | sc-429658 | m | Gene Knockout | GFP | 0 | ||
group IVD sPLA2 HDR 플라스미드 (m) | sc-429658-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
group IVD sPLA2 더블 틈내기효소 플라스미드 (m) | sc-429658-NIC | m | Gene Knockout | Puromycin | 0 | ||
group IVD sPLA2 더블 틈내기효소 플라스미드 (m2) | sc-429658-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
group IVE sPLA2 CRISPR/Cas9 케이오 플라스미드 (h) | sc-417296 | h | Gene Knockout | GFP | 0 | ||
group IVE sPLA2 HDR 플라스미드 (h) | sc-417296-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
group IVE sPLA2 더블 틈내기효소 플라스미드 (h) | sc-417296-NIC | h | Gene Knockout | Puromycin | 0 | ||
group IVE sPLA2 더블 틈내기효소 플라스미드 (h2) | sc-417296-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
group IVE sPLA2 CRISPR/Cas9 케이오 플라스미드 (m) | sc-435951 | m | Gene Knockout | GFP | 0 | ||
group IVE sPLA2 HDR 플라스미드 (m) | sc-435951-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
group IVE sPLA2 더블 틈내기효소 플라스미드 (m) | sc-435951-NIC | m | Gene Knockout | Puromycin | 0 | ||
group IVE sPLA2 더블 틈내기효소 플라스미드 (m2) | sc-435951-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
group IVF sPLA2 CRISPR/Cas9 케이오 플라스미드 (h) | sc-415215 | h | Gene Knockout | GFP | 0 | ||
group IVF sPLA2 HDR 플라스미드 (h) | sc-415215-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
group IVF sPLA2 더블 틈내기효소 플라스미드 (h) | sc-415215-NIC | h | Gene Knockout | Puromycin | 0 | ||
group IVF sPLA2 더블 틈내기효소 플라스미드 (h2) | sc-415215-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
group IVF sPLA2 CRISPR/Cas9 케이오 플라스미드 (m) | sc-435454 | m | Gene Knockout | GFP | 0 | ||
group IVF sPLA2 HDR 플라스미드 (m) | sc-435454-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
group IVF sPLA2 더블 틈내기효소 플라스미드 (m) | sc-435454-NIC | m | Gene Knockout | Puromycin | 0 | ||
group IVF sPLA2 더블 틈내기효소 플라스미드 (m2) | sc-435454-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
group V PLA2 CRISPR/Cas9 케이오 플라스미드 (h) | sc-409663 | h | Gene Knockout | GFP | 0 | ||
group V PLA2 HDR 플라스미드 (h) | sc-409663-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
group V PLA2 더블 틈내기효소 플라스미드 (h) | sc-409663-NIC | h | Gene Knockout | Puromycin | 0 | ||
group V PLA2 더블 틈내기효소 플라스미드 (h2) | sc-409663-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
group V PLA2 CRISPR/Cas9 케이오 플라스미드 (m) | sc-422285 | m | Gene Knockout | GFP | 0 | ||
group V PLA2 HDR 플라스미드 (m) | sc-422285-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
group V PLA2 더블 틈내기효소 플라스미드 (m) | sc-422285-NIC | m | Gene Knockout | Puromycin | 0 | ||
group V PLA2 더블 틈내기효소 플라스미드 (m2) | sc-422285-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
group VI iPLA2 CRISPR/Cas9 케이오 플라스미드 (h) | sc-402107 | h | Gene Knockout | GFP | 1 | ||
group VI iPLA2 HDR 플라스미드 (h) | sc-402107-HDR | h | Homology Directed Repair | Puromycin | 1 | ||
group VI iPLA2 더블 틈내기효소 플라스미드 (h) | sc-402107-NIC | h | Gene Knockout | Puromycin | 1 | ||
group VI iPLA2 더블 틈내기효소 플라스미드 (h2) | sc-402107-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
group VI iPLA2 CRISPR/Cas9 케이오 플라스미드 (m) | sc-424697 | m | Gene Knockout | GFP | 0 | ||
group VI iPLA2 HDR 플라스미드 (m) | sc-424697-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
group VI iPLA2 더블 틈내기효소 플라스미드 (m) | sc-424697-NIC | m | Gene Knockout | Puromycin | 0 | ||
group VI iPLA2 더블 틈내기효소 플라스미드 (m2) | sc-424697-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
group X sPLA2 CRISPR/Cas9 케이오 플라스미드 (h) | sc-416644 | h | Gene Knockout | GFP | 0 | ||
group X sPLA2 HDR 플라스미드 (h) | sc-416644-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
group X sPLA2 더블 틈내기효소 플라스미드 (h) | sc-416644-NIC | h | Gene Knockout | Puromycin | 0 | ||
group X sPLA2 더블 틈내기효소 플라스미드 (h2) | sc-416644-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
group X sPLA2 CRISPR/Cas9 케이오 플라스미드 (m) | sc-424101 | m | Gene Knockout | GFP | 0 | ||
group X sPLA2 HDR 플라스미드 (m) | sc-424101-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
group X sPLA2 더블 틈내기효소 플라스미드 (m) | sc-424101-NIC | m | Gene Knockout | Puromycin | 0 | ||
group X sPLA2 더블 틈내기효소 플라스미드 (m2) | sc-424101-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
group XIIA sPLA2 CRISPR/Cas9 케이오 플라스미드 (h) | sc-408023 | h | Gene Knockout | GFP | 0 | ||
group XIIA sPLA2 HDR 플라스미드 (h) | sc-408023-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
group XIIA sPLA2 더블 틈내기효소 플라스미드 (h) | sc-408023-NIC | h | Gene Knockout | Puromycin | 0 | ||
group XIIA sPLA2 더블 틈내기효소 플라스미드 (h2) | sc-408023-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
group XIIA sPLA2 CRISPR/Cas9 케이오 플라스미드 (m) | sc-425967 | m | Gene Knockout | GFP | 0 | ||
group XIIA sPLA2 HDR 플라스미드 (m) | sc-425967-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
group XIIA sPLA2 더블 틈내기효소 플라스미드 (m) | sc-425967-NIC | m | Gene Knockout | Puromycin | 0 | ||
group XIIA sPLA2 더블 틈내기효소 플라스미드 (m2) | sc-425967-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
group XIIB sPLA2 CRISPR/Cas9 케이오 플라스미드 (h) | sc-413682 | h | Gene Knockout | GFP | 0 | ||
group XIIB sPLA2 HDR 플라스미드 (h) | sc-413682-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
group XIIB sPLA2 더블 틈내기효소 플라스미드 (h) | sc-413682-NIC | h | Gene Knockout | Puromycin | 0 | ||
group XIIB sPLA2 더블 틈내기효소 플라스미드 (h2) | sc-413682-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
group XIIB sPLA2 CRISPR/Cas9 케이오 플라스미드 (m) | sc-427553 | m | Gene Knockout | GFP | 0 | ||
group XIIB sPLA2 HDR 플라스미드 (m) | sc-427553-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
group XIIB sPLA2 더블 틈내기효소 플라스미드 (m) | sc-427553-NIC | m | Gene Knockout | Puromycin | 0 | ||
group XIIB sPLA2 더블 틈내기효소 플라스미드 (m2) | sc-427553-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
JMJD7-PLA2G4B CRISPR/Cas9 케이오 플라스미드 (h) | sc-418409 | h | Gene Knockout | GFP | 0 | ||
JMJD7-PLA2G4B HDR 플라스미드 (h) | sc-418409-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
JMJD7-PLA2G4B 더블 틈내기효소 플라스미드 (h) | sc-418409-NIC | h | Gene Knockout | Puromycin | 0 | ||
JMJD7-PLA2G4B 더블 틈내기효소 플라스미드 (h2) | sc-418409-NIC-2 | h | Gene Knockout | Puromycin | 0 |
Phospholipase A2 CRISPR Activation Products
| Empty Table Header | 제품명 | 카탈로그# | Species | APPLICATIONS | MARKER | 引用 | RATING |
|---|---|---|---|---|---|---|---|
group IB sPLA2 CRISPR 활성화 플라스미드(h) | sc-407667-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IB sPLA2 CRISPR 활성화 플라스미드(h2) | sc-407667-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IB sPLA2 렌티바이러스의 활성화 입자 (h) | sc-407667-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IB sPLA2 렌티바이러스의 활성화 입자 (h2) | sc-407667-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IB sPLA2 CRISPR 활성화 플라스미드(m) | sc-422279-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IB sPLA2 CRISPR 활성화 플라스미드(m2) | sc-422279-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IB sPLA2 렌티바이러스의 활성화 입자 (m) | sc-422279-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IB sPLA2 렌티바이러스의 활성화 입자 (m2) | sc-422279-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group II sPLA2 CRISPR Activation Plasmid (h) | sc-402234-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group II sPLA2 CRISPR Activation Plasmid (h2) | sc-402234-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group II sPLA2 Lentiviral Activation Particles (h) | sc-402234-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group II sPLA2 Lentiviral Activation Particles (h2) | sc-402234-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group II sPLA2 CRISPR 활성화 플라스미드(m) | sc-422281-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group II sPLA2 CRISPR 활성화 플라스미드(m2) | sc-422281-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group II sPLA2 렌티바이러스의 활성화 입자 (m) | sc-422281-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group II sPLA2 렌티바이러스의 활성화 입자 (m2) | sc-422281-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIC sPLA2 CRISPR 활성화 플라스미드(h) | sc-415910-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIC sPLA2 CRISPR 활성화 플라스미드(h2) | sc-415910-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIC sPLA2 렌티바이러스의 활성화 입자 (h) | sc-415910-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIC sPLA2 렌티바이러스의 활성화 입자 (h2) | sc-415910-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIC sPLA2 CRISPR 활성화 플라스미드(m) | sc-422282-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIC sPLA2 CRISPR 활성화 플라스미드(m2) | sc-422282-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIC sPLA2 렌티바이러스의 활성화 입자 (m) | sc-422282-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIC sPLA2 렌티바이러스의 활성화 입자 (m2) | sc-422282-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IID sPLA2 CRISPR 활성화 플라스미드(h) | sc-411908-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
group IID sPLA2 CRISPR 활성화 플라스미드(h2) | sc-411908-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
group IID sPLA2 렌티바이러스의 활성화 입자 (h) | sc-411908-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
group IID sPLA2 렌티바이러스의 활성화 입자 (h2) | sc-411908-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
group IID sPLA2 CRISPR 활성화 플라스미드(m) | sc-422283-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IID sPLA2 CRISPR 활성화 플라스미드(m2) | sc-422283-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IID sPLA2 렌티바이러스의 활성화 입자 (m) | sc-422283-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IID sPLA2 렌티바이러스의 활성화 입자 (m2) | sc-422283-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIE sPLA2 CRISPR 활성화 플라스미드(h) | sc-408058-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIE sPLA2 CRISPR 활성화 플라스미드(h2) | sc-408058-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIE sPLA2 렌티바이러스의 활성화 입자 (h) | sc-408058-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIE sPLA2 렌티바이러스의 활성화 입자 (h2) | sc-408058-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIE sPLA2 CRISPR 활성화 플라스미드(m) | sc-424164-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIE sPLA2 CRISPR 활성화 플라스미드(m2) | sc-424164-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIE sPLA2 렌티바이러스의 활성화 입자 (m) | sc-424164-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIE sPLA2 Lentiviral Activation Particles (m2) | sc-424164-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIF sPLA2 CRISPR 활성화 플라스미드(h) | sc-410098-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIF sPLA2 CRISPR 활성화 플라스미드(h2) | sc-410098-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIF sPLA2 렌티바이러스의 활성화 입자 (h) | sc-410098-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIF sPLA2 렌티바이러스의 활성화 입자 (h2) | sc-410098-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIF sPLA2 CRISPR 활성화 플라스미드(m) | sc-424165-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIF sPLA2 CRISPR 활성화 플라스미드(m2) | sc-424165-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIF sPLA2 렌티바이러스의 활성화 입자 (m) | sc-424165-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IIF sPLA2 Lentiviral Activation Particles (m2) | sc-424165-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group III sPLA2 CRISPR 활성화 플라스미드(h) | sc-412075-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group III sPLA2 CRISPR 활성화 플라스미드(h2) | sc-412075-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group III sPLA2 렌티바이러스의 활성화 입자 (h) | sc-412075-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group III sPLA2 렌티바이러스의 활성화 입자 (h2) | sc-412075-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group III sPLA2 CRISPR 활성화 플라스미드(m) | sc-433569-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group III sPLA2 CRISPR 활성화 플라스미드(m2) | sc-433569-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group III sPLA2 렌티바이러스의 활성화 입자 (m) | sc-433569-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group III sPLA2 Lentiviral Activation Particles (m2) | sc-433569-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVB sPLA2 CRISPR 활성화 플라스미드(h) | sc-410470-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVB sPLA2 CRISPR 활성화 플라스미드(h2) | sc-410470-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVB sPLA2 렌티바이러스의 활성화 입자 (h) | sc-410470-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVB sPLA2 렌티바이러스의 활성화 입자 (h2) | sc-410470-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVC sPLA2 CRISPR 활성화 플라스미드(h) | sc-411191-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVC sPLA2 CRISPR 활성화 플라스미드(h2) | sc-411191-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVC sPLA2 렌티바이러스의 활성화 입자 (h) | sc-411191-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVC sPLA2 렌티바이러스의 활성화 입자 (h2) | sc-411191-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVC sPLA2 CRISPR 활성화 플라스미드(m) | sc-433207-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVC sPLA2 CRISPR 활성화 플라스미드(m2) | sc-433207-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVC sPLA2 렌티바이러스의 활성화 입자 (m) | sc-433207-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVC sPLA2 Lentiviral Activation Particles (m2) | sc-433207-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVD sPLA2 CRISPR 활성화 플라스미드(h) | sc-415332-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVD sPLA2 CRISPR 활성화 플라스미드(h2) | sc-415332-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVD sPLA2 렌티바이러스의 활성화 입자 (h) | sc-415332-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVD sPLA2 렌티바이러스의 활성화 입자 (h2) | sc-415332-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVD sPLA2 CRISPR 활성화 플라스미드(m) | sc-429658-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVD sPLA2 CRISPR 활성화 플라스미드(m2) | sc-429658-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVD sPLA2 렌티바이러스의 활성화 입자 (m) | sc-429658-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVD sPLA2 Lentiviral Activation Particles (m2) | sc-429658-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVE sPLA2 CRISPR 활성화 플라스미드(h) | sc-417296-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVE sPLA2 CRISPR 활성화 플라스미드(h2) | sc-417296-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVE sPLA2 렌티바이러스의 활성화 입자 (h) | sc-417296-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVE sPLA2 렌티바이러스의 활성화 입자 (h2) | sc-417296-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVE sPLA2 CRISPR 활성화 플라스미드(m) | sc-435951-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVE sPLA2 CRISPR 활성화 플라스미드(m2) | sc-435951-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVE sPLA2 렌티바이러스의 활성화 입자 (m) | sc-435951-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVE sPLA2 Lentiviral Activation Particles (m2) | sc-435951-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVF sPLA2 CRISPR 활성화 플라스미드(h) | sc-415215-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVF sPLA2 CRISPR 활성화 플라스미드(h2) | sc-415215-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVF sPLA2 렌티바이러스의 활성화 입자 (h) | sc-415215-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVF sPLA2 렌티바이러스의 활성화 입자 (h2) | sc-415215-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVF sPLA2 CRISPR 활성화 플라스미드(m) | sc-435454-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVF sPLA2 CRISPR 활성화 플라스미드(m2) | sc-435454-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVF sPLA2 렌티바이러스의 활성화 입자 (m) | sc-435454-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group IVF sPLA2 Lentiviral Activation Particles (m2) | sc-435454-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group V PLA2 CRISPR 활성화 플라스미드(h) | sc-409663-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group V PLA2 CRISPR 활성화 플라스미드(h2) | sc-409663-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group V PLA2 렌티바이러스의 활성화 입자 (h) | sc-409663-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group V PLA2 렌티바이러스의 활성화 입자 (h2) | sc-409663-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group V PLA2 CRISPR 활성화 플라스미드(m) | sc-422285-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group V PLA2 CRISPR 활성화 플라스미드(m2) | sc-422285-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group V PLA2 렌티바이러스의 활성화 입자 (m) | sc-422285-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group V PLA2 렌티바이러스의 활성화 입자 (m2) | sc-422285-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group VI iPLA2 CRISPR 활성화 플라스미드(h) | sc-402107-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
group VI iPLA2 CRISPR 활성화 플라스미드(h2) | sc-402107-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
group VI iPLA2 렌티바이러스의 활성화 입자 (h) | sc-402107-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
group VI iPLA2 렌티바이러스의 활성화 입자 (h2) | sc-402107-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
group VI iPLA2 CRISPR 활성화 플라스미드(m) | sc-424697-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group VI iPLA2 CRISPR 활성화 플라스미드(m2) | sc-424697-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group VI iPLA2 렌티바이러스의 활성화 입자 (m) | sc-424697-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group VI iPLA2 Lentiviral Activation Particles (m2) | sc-424697-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group X sPLA2 CRISPR 활성화 플라스미드(h) | sc-416644-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group X sPLA2 CRISPR 활성화 플라스미드(h2) | sc-416644-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group X sPLA2 렌티바이러스의 활성화 입자 (h) | sc-416644-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group X sPLA2 렌티바이러스의 활성화 입자 (h2) | sc-416644-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group X sPLA2 CRISPR 활성화 플라스미드(m) | sc-424101-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group X sPLA2 CRISPR 활성화 플라스미드(m2) | sc-424101-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group X sPLA2 렌티바이러스의 활성화 입자 (m) | sc-424101-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group X sPLA2 Lentiviral Activation Particles (m2) | sc-424101-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group XIIA sPLA2 CRISPR 활성화 플라스미드(h) | sc-408023-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group XIIA sPLA2 CRISPR 활성화 플라스미드(h2) | sc-408023-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group XIIA sPLA2 렌티바이러스의 활성화 입자 (h) | sc-408023-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group XIIA sPLA2 렌티바이러스의 활성화 입자 (h2) | sc-408023-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group XIIA sPLA2 CRISPR 활성화 플라스미드(m) | sc-425967-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group XIIA sPLA2 CRISPR 활성화 플라스미드(m2) | sc-425967-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group XIIA sPLA2 렌티바이러스의 활성화 입자 (m) | sc-425967-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group XIIA sPLA2 Lentiviral Activation Particles (m2) | sc-425967-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group XIIB sPLA2 CRISPR 활성화 플라스미드(h) | sc-413682-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group XIIB sPLA2 CRISPR 활성화 플라스미드(h2) | sc-413682-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group XIIB sPLA2 렌티바이러스의 활성화 입자 (h) | sc-413682-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group XIIB sPLA2 렌티바이러스의 활성화 입자 (h2) | sc-413682-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
group XIIB sPLA2 CRISPR 활성화 플라스미드(m) | sc-427553-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group XIIB sPLA2 CRISPR 활성화 플라스미드(m2) | sc-427553-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group XIIB sPLA2 렌티바이러스의 활성화 입자 (m) | sc-427553-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
group XIIB sPLA2 Lentiviral Activation Particles (m2) | sc-427553-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
JMJD7-PLA2G4B CRISPR 활성화 플라스미드(h) | sc-418409-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
JMJD7-PLA2G4B CRISPR 활성화 플라스미드(h2) | sc-418409-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
JMJD7-PLA2G4B 렌티바이러스의 활성화 입자 (h) | sc-418409-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
JMJD7-PLA2G4B 렌티바이러스의 활성화 입자 (h2) | sc-418409-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 |
Phospholipase A2 siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | 제품명 | 카탈로그# | Species | APPLICATIONS | MARKER | 引用 | RATING |
|---|---|---|---|---|---|---|---|
group IB sPLA2 siRNA (h) | sc-96105 | h | Gene Silencing | N/A | 0 | ||
group IB sPLA2 shRNA 플라스미드 (h) | sc-96105-SH | h | Gene Silencing | Puromycin | 0 | ||
group IB sPLA2 shRNA (h)렌티바이러스의 입자 | sc-96105-V | h | Gene Silencing | Puromycin | 0 | ||
group IB sPLA2 siRNA (m) | sc-145770 | m | Gene Silencing | N/A | 0 | ||
group IB sPLA2 shRNA 플라스미드 (m) | sc-145770-SH | m | Gene Silencing | Puromycin | 0 | ||
group IB sPLA2 shRNA (m)렌티바이러스의 입자 | sc-145770-V | m | Gene Silencing | Puromycin | 0 | ||
group II sPLA2 siRNA (h) | sc-43817 | h | Gene Silencing | N/A | 0 | ||
group II sPLA2 shRNA 플라스미드 (h) | sc-43817-SH | h | Gene Silencing | Puromycin | 0 | ||
group II sPLA2 shRNA (h)렌티바이러스의 입자 | sc-43817-V | h | Gene Silencing | Puromycin | 0 | ||
group II sPLA2 siRNA (m) | sc-43818 | m | Gene Silencing | N/A | 1 | ||
group II sPLA2 shRNA 플라스미드 (m) | sc-43818-SH | m | Gene Silencing | Puromycin | 1 | ||
group II sPLA2 shRNA (m)렌티바이러스의 입자 | sc-43818-V | m | Gene Silencing | Puromycin | 1 | ||
group IIC sPLA2 siRNA (m) | sc-145771 | m | Gene Silencing | N/A | 0 | ||
group IIC sPLA2 siRNA (r) | sc-270118 | r | Gene Silencing | N/A | 0 | ||
group IIC sPLA2 shRNA 플라스미드 (m) | sc-145771-SH | m | Gene Silencing | Puromycin | 0 | ||
group IIC sPLA2 shRNA (m)렌티바이러스의 입자 | sc-145771-V | m | Gene Silencing | Puromycin | 0 | ||
group IIC sPLA2 shRNA 플라스미드 (r) | sc-270118-SH | r | Gene Silencing | Puromycin | 0 | ||
group IIC sPLA2 shRNA (r)렌티바이러스의 입자 | sc-270118-V | r | Gene Silencing | Puromycin | 0 | ||
group IID sPLA2 siRNA (h) | sc-78911 | h | Gene Silencing | N/A | 0 | ||
group IID sPLA2 shRNA 플라스미드 (h) | sc-78911-SH | h | Gene Silencing | Puromycin | 0 | ||
group IID sPLA2 shRNA (h)렌티바이러스의 입자 | sc-78911-V | h | Gene Silencing | Puromycin | 0 | ||
group IID sPLA2 siRNA (m) | sc-105417 | m | Gene Silencing | N/A | 0 | ||
group IID sPLA2 shRNA 플라스미드 (m) | sc-105417-SH | m | Gene Silencing | Puromycin | 0 | ||
group IID sPLA2 shRNA (m)렌티바이러스의 입자 | sc-105417-V | m | Gene Silencing | Puromycin | 0 | ||
group IIE sPLA2 siRNA (h) | sc-88254 | h | Gene Silencing | N/A | 0 | ||
group IIE sPLA2 shRNA 플라스미드 (h) | sc-88254-SH | h | Gene Silencing | Puromycin | 0 | ||
group IIE sPLA2 shRNA (h)렌티바이러스의 입자 | sc-88254-V | h | Gene Silencing | Puromycin | 0 | ||
group IIE sPLA2 siRNA (m) | sc-105418 | m | Gene Silencing | N/A | 0 | ||
group IIE sPLA2 shRNA 플라스미드 (m) | sc-105418-SH | m | Gene Silencing | Puromycin | 0 | ||
group IIE sPLA2 shRNA (m)렌티바이러스의 입자 | sc-105418-V | m | Gene Silencing | Puromycin | 0 | ||
group IIF sPLA2 siRNA (h) | sc-88430 | h | Gene Silencing | N/A | 0 | ||
group IIF sPLA2 shRNA 플라스미드 (h) | sc-88430-SH | h | Gene Silencing | Puromycin | 0 | ||
group IIF sPLA2 shRNA (h)렌티바이러스의 입자 | sc-88430-V | h | Gene Silencing | Puromycin | 0 | ||
group IIF sPLA2 siRNA (m) | sc-145772 | m | Gene Silencing | N/A | 0 | ||
group IIF sPLA2 shRNA 플라스미드 (m) | sc-145772-SH | m | Gene Silencing | Puromycin | 0 | ||
group IIF sPLA2 shRNA (m)렌티바이러스의 입자 | sc-145772-V | m | Gene Silencing | Puromycin | 0 | ||
group III sPLA2 siRNA (h) | sc-75201 | h | Gene Silencing | N/A | 0 | ||
group III sPLA2 shRNA 플라스미드 (h) | sc-75201-SH | h | Gene Silencing | Puromycin | 0 | ||
group III sPLA2 shRNA (h)렌티바이러스의 입자 | sc-75201-V | h | Gene Silencing | Puromycin | 0 | ||
group III sPLA2 siRNA (m) | sc-145773 | m | Gene Silencing | N/A | 0 | ||
group III sPLA2 shRNA 플라스미드 (m) | sc-145773-SH | m | Gene Silencing | Puromycin | 0 | ||
group III sPLA2 shRNA (m)렌티바이러스의 입자 | sc-145773-V | m | Gene Silencing | Puromycin | 0 | ||
group IVB sPLA2 siRNA (h) | sc-90277 | h | Gene Silencing | N/A | 0 | ||
group IVB sPLA2 shRNA 플라스미드 (h) | sc-90277-SH | h | Gene Silencing | Puromycin | 0 | ||
group IVB sPLA2 shRNA (h)렌티바이러스의 입자 | sc-90277-V | h | Gene Silencing | Puromycin | 0 | ||
group IVC sPLA2 siRNA (h) | sc-97603 | h | Gene Silencing | N/A | 0 | ||
group IVC sPLA2 shRNA 플라스미드 (h) | sc-97603-SH | h | Gene Silencing | Puromycin | 0 | ||
group IVC sPLA2 shRNA (h)렌티바이러스의 입자 | sc-97603-V | h | Gene Silencing | Puromycin | 0 | ||
group IVC sPLA2 siRNA (m) | sc-145775 | m | Gene Silencing | N/A | 0 | ||
group IVC sPLA2 shRNA 플라스미드 (m) | sc-145775-SH | m | Gene Silencing | Puromycin | 0 | ||
group IVC sPLA2 shRNA (m)렌티바이러스의 입자 | sc-145775-V | m | Gene Silencing | Puromycin | 0 | ||
group IVD sPLA2 siRNA (h) | sc-90240 | h | Gene Silencing | N/A | 0 | ||
group IVD sPLA2 shRNA 플라스미드 (h) | sc-90240-SH | h | Gene Silencing | Puromycin | 0 | ||
group IVD sPLA2 shRNA (h)렌티바이러스의 입자 | sc-90240-V | h | Gene Silencing | Puromycin | 0 | ||
group IVD sPLA2 siRNA (m) | sc-145776 | m | Gene Silencing | N/A | 0 | ||
group IVD sPLA2 shRNA 플라스미드 (m) | sc-145776-SH | m | Gene Silencing | Puromycin | 0 | ||
group IVD sPLA2 shRNA (m)렌티바이러스의 입자 | sc-145776-V | m | Gene Silencing | Puromycin | 0 | ||
group IVE sPLA2 siRNA (h) | sc-90083 | h | Gene Silencing | N/A | 0 | ||
group IVE sPLA2 shRNA 플라스미드 (h) | sc-90083-SH | h | Gene Silencing | Puromycin | 0 | ||
group IVE sPLA2 shRNA (h)렌티바이러스의 입자 | sc-90083-V | h | Gene Silencing | Puromycin | 0 | ||
group IVE sPLA2 siRNA (m) | sc-145777 | m | Gene Silencing | N/A | 0 | ||
group IVE sPLA2 shRNA 플라스미드 (m) | sc-145777-SH | m | Gene Silencing | Puromycin | 0 | ||
group IVE sPLA2 shRNA (m)렌티바이러스의 입자 | sc-145777-V | m | Gene Silencing | Puromycin | 0 | ||
group IVF sPLA2 siRNA (h) | sc-90284 | h | Gene Silencing | N/A | 0 | ||
group IVF sPLA2 shRNA 플라스미드 (h) | sc-90284-SH | h | Gene Silencing | Puromycin | 0 | ||
group IVF sPLA2 shRNA (h)렌티바이러스의 입자 | sc-90284-V | h | Gene Silencing | Puromycin | 0 | ||
group IVF sPLA2 siRNA (m) | sc-145778 | m | Gene Silencing | N/A | 0 | ||
group IVF sPLA2 shRNA 플라스미드 (m) | sc-145778-SH | m | Gene Silencing | Puromycin | 0 | ||
group IVF sPLA2 shRNA (m)렌티바이러스의 입자 | sc-145778-V | m | Gene Silencing | Puromycin | 0 | ||
group V PLA2 siRNA (h) | sc-44023 | h | Gene Silencing | N/A | 0 | ||
group V PLA2 shRNA 플라스미드 (h) | sc-44023-SH | h | Gene Silencing | Puromycin | 0 | ||
group V PLA2 shRNA (h)렌티바이러스의 입자 | sc-44023-V | h | Gene Silencing | Puromycin | 0 | ||
group V PLA2 siRNA (m) | sc-62825 | m | Gene Silencing | N/A | 0 | ||
group V PLA2 shRNA 플라스미드 (m) | sc-62825-SH | m | Gene Silencing | Puromycin | 0 | ||
group V PLA2 shRNA (m)렌티바이러스의 입자 | sc-62825-V | m | Gene Silencing | Puromycin | 0 | ||
group V PLA2 shRNA (r)렌티바이러스의 입자 | sc-270119-V | r | Gene Silencing | Puromycin | 0 | ||
group V PLA2shRNA Plasmid (r) shRNA 플라스미드 (r) | sc-270119-SH | r | Gene Silencing | Puromycin | 0 | ||
group V PLA2siRNA (r) siRNA (r) | sc-270119 | r | Gene Silencing | N/A | 0 | ||
group VI iPLA2 siRNA (h) | sc-43819 | h | Gene Silencing | N/A | 0 | ||
group VI iPLA2 shRNA 플라스미드 (h) | sc-43819-SH | h | Gene Silencing | Puromycin | 0 | ||
group VI iPLA2 shRNA (h)렌티바이러스의 입자 | sc-43819-V | h | Gene Silencing | Puromycin | 0 | ||
group VI iPLA2 siRNA (m) | sc-43820 | m | Gene Silencing | N/A | 0 | ||
group VI iPLA2 shRNA 플라스미드 (m) | sc-43820-SH | m | Gene Silencing | Puromycin | 0 | ||
group VI iPLA2 shRNA (m)렌티바이러스의 입자 | sc-43820-V | m | Gene Silencing | Puromycin | 0 | ||
group VI iPLA2 siRNA (r) | sc-270117 | r | Gene Silencing | N/A | 0 | ||
group VI iPLA2 shRNA (r)렌티바이러스의 입자 | sc-270117-V | r | Gene Silencing | Puromycin | 0 | ||
group VI iPLA2shRNA Plasmid (r) shRNA 플라스미드 (r) | sc-270117-SH | r | Gene Silencing | Puromycin | 0 | ||
group X sPLA2 siRNA (h) | sc-43821 | h | Gene Silencing | N/A | 0 | ||
group X sPLA2 shRNA 플라스미드 (h) | sc-43821-SH | h | Gene Silencing | Puromycin | 0 | ||
group X sPLA2 shRNA (h)렌티바이러스의 입자 | sc-43821-V | h | Gene Silencing | Puromycin | 0 | ||
group X sPLA2 siRNA (m) | sc-60031 | m | Gene Silencing | N/A | 0 | ||
group X sPLA2 shRNA 플라스미드 (m) | sc-60031-SH | m | Gene Silencing | Puromycin | 0 | ||
group X sPLA2 shRNA (m)렌티바이러스의 입자 | sc-60031-V | m | Gene Silencing | Puromycin | 0 | ||
group XIIA sPLA2 siRNA (h) | sc-89136 | h | Gene Silencing | N/A | 0 | ||
group XIIA sPLA2 shRNA 플라스미드 (h) | sc-89136-SH | h | Gene Silencing | Puromycin | 0 | ||
group XIIA sPLA2 shRNA (h)렌티바이러스의 입자 | sc-89136-V | h | Gene Silencing | Puromycin | 0 | ||
group XIIA sPLA2 siRNA (m) | sc-105419 | m | Gene Silencing | N/A | 0 | ||
group XIIA sPLA2 shRNA 플라스미드 (m) | sc-105419-SH | m | Gene Silencing | Puromycin | 0 | ||
group XIIA sPLA2 shRNA (m)렌티바이러스의 입자 | sc-105419-V | m | Gene Silencing | Puromycin | 0 | ||
group XIIB sPLA2 siRNA (h) | sc-90439 | h | Gene Silencing | N/A | 0 | ||
group XIIB sPLA2 shRNA 플라스미드 (h) | sc-90439-SH | h | Gene Silencing | Puromycin | 0 | ||
group XIIB sPLA2 shRNA (h)렌티바이러스의 입자 | sc-90439-V | h | Gene Silencing | Puromycin | 0 | ||
group XIIB sPLA2 siRNA (m) | sc-145779 | m | Gene Silencing | N/A | 0 | ||
group XIIB sPLA2 shRNA 플라스미드 (m) | sc-145779-SH | m | Gene Silencing | Puromycin | 0 | ||
group XIIB sPLA2 shRNA (m)렌티바이러스의 입자 | sc-145779-V | m | Gene Silencing | Puromycin | 0 |